Dapagliflozin administration to a mouse model of type 2 diabetes induces DNA methylation and gene expression changes in pancreatic islets
-
Published:2024-09
Issue:
Volume:725
Page:150254
-
ISSN:0006-291X
-
Container-title:Biochemical and Biophysical Research Communications
-
language:en
-
Short-container-title:Biochemical and Biophysical Research Communications
Author:
Yokoi Aisha,
Asahara Shun-ichiroORCID,
Inoue Hiroyuki,
Seike Masako,
Kido Nozomi,
Suzuki Hirotaka,
Kanno Ayumi,
Kimura-Koyanagi Maki,
Kido Yoshiaki,
Ogawa Wataru
Reference27 articles.
1. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021;Lancet,2023
2. EMPA-REG OUTCOME Investigators, Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabete;Zinman;N. Engl. J. Med.,2015
3. CANVAS Program Collaborative Group, Canagliflozin and cardiovascular and renal events in type 2 diabetes;Neal;N. Engl. J. Med.,2017
4. DECLARE–TIMI 58 Investigators, Dapagliflozin and cardiovascular outcomes in type 2 diabetes;Wiviott;N. Engl. J. Med.,2019
5. Canagliflozin and renal outcomes in type 2 diabetes and nephropathy;Perkovic;N. Engl. J. Med.,2019